![Emil Kakkis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emil Kakkis
Fondatore presso
ULTRAGENYX PHARMACEUTICAL INC.
Patrimonio netto: 65 M $ in data 31/05/2026
Profilo
Emil D. Kakkis ha fondato Ultragenyx Pharmaceutical, Inc. e Everylife Foundation for Rare Diseases. Il Dr. Kakkis occupa la posizione di presidente, amministratore delegato e direttore di Ultragenyx Pharmaceutical, Inc. Il Dr. Kakkis è anche nel consiglio di Emil Kakkis & Jenny Soriano Living Trust e Odylia Therapeutics e presidente della Everylife Foundation for Rare Diseases. Nella sua carriera passata il Dr. Kakkis è stato Chief Medical Officer e Senior Vice President per BioMarin Pharmaceutical, Inc. e Assistant Professor all'Harbor-UCLA Medical Center. Il Dr. Kakkis ha conseguito una laurea al Pomona College e un dottorato alla David Geffen School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/04/2026 | 2.694.724 ( 2,74% ) | 65 M $ | 31/05/2026 |
Ultime notizie su Emil Kakkis
Posizioni attive di Emil Kakkis
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Fondatore | 22/04/2010 |
Emil Kakkis & Jenny Soriano Living Trust | Direttore/Membro del Consiglio | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Fondatore | 01/03/2009 |
Odylia Therapeutics
 Odylia Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit biotech that develops therapies for rare diseases | Direttore/Membro del Consiglio | 01/01/2019 |
Precedenti posizioni note di Emil Kakkis
| Società | Posizione | Fine |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | 27/02/2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Corporate Officer/Principal | 01/01/1998 |
Formazione di Emil Kakkis
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Health Services |
Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Commercial Services |
Odylia Therapeutics
Odylia Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit biotech that develops therapies for rare diseases | Commercial Services |
